99 related articles for article (PubMed ID: 21105341)
21. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
22. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
23. Sensory cell regeneration and stem cells: what we have already achieved in the management of deafness.
Vlastarakos PV; Nikolopoulos TP; Tavoulari E; Papacharalambous G; Tzagaroulakis A; Dazert S
Otol Neurotol; 2008 Sep; 29(6):758-68. PubMed ID: 18665007
[TBL] [Abstract][Full Text] [Related]
24. [Regenerative potential in the organ of Corti after otic intoxication].
Lenoir M; Daudet N; Parietti C; Humbert G; Ripoll C; Gallego M; Pujol R; Vago P
J Soc Biol; 2000; 194(3-4):159-64. PubMed ID: 11324318
[TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside ototoxicity: a human temporal bone study.
Hinojosa R; Nelson EG; Lerner SA; Redleaf MI; Schramm DR
Laryngoscope; 2001 Oct; 111(10):1797-805. PubMed ID: 11801948
[TBL] [Abstract][Full Text] [Related]
26. Nitro-L-arginine methyl ester: a potential protector against gentamicin ototoxicity.
Nordang L; Anniko M
Acta Otolaryngol; 2005 Oct; 125(10):1033-8. PubMed ID: 16298782
[TBL] [Abstract][Full Text] [Related]
27. [Specific ototoxic effects of monomycin in immature animals].
Bogomil'skiĭ MR; Dreval' AA; D'iakonova IN; Rakhmanova IV; Tikhomirov AM; Iarygin VN
Vestn Otorinolaringol; 2009; (5):26-9. PubMed ID: 20037552
[TBL] [Abstract][Full Text] [Related]
28. A sensitive animal model to assess acute and chronic ototoxic effects.
Lautermann J; Schacht J
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):837-40. PubMed ID: 8703385
[TBL] [Abstract][Full Text] [Related]
29. Ototoxicity of an ototopic preparation--experimental results and clinical facts.
Halama AR; Wright CG; Meyerhoff WL
Acta Otorhinolaryngol Belg; 1991; 45(3):279-82. PubMed ID: 1950546
[TBL] [Abstract][Full Text] [Related]
30. An animal model of hearing loss from alpha-difluoromethylornithine.
Jansen C; Mattox DE; Miller KD; Brownell WE
Arch Otolaryngol Head Neck Surg; 1989 Oct; 115(10):1234-7. PubMed ID: 2506912
[TBL] [Abstract][Full Text] [Related]
31. Temporal bone histopathologic abnormalities associated with mitochondrial mutation T7511C.
Ishikawa K; Tamagawa Y; Takahashi K; Iino Y; Murakami Y; Kakizaki K; Kimura H; Kusakari J; Hara A; Ichimura K
Laryngoscope; 2006 Nov; 116(11):1982-6. PubMed ID: 17075421
[TBL] [Abstract][Full Text] [Related]
32. Scar formation in mice deafened with kanamycin and furosemide.
Żak M; van der Linden CA; Bezdjian A; Hendriksen FG; Klis SF; Grolman W
Microsc Res Tech; 2016 Aug; 79(8):766-72. PubMed ID: 27311812
[TBL] [Abstract][Full Text] [Related]
33. The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea.
Nishimura B; Tabuchi K; Nakamagoe M; Hara A
Neurosci Lett; 2010 Nov; 485(1):1-5. PubMed ID: 20709153
[TBL] [Abstract][Full Text] [Related]
34. Temporal bone histopathology in alport syndrome.
Merchant SN; Burgess BJ; Adams JC; Kashtan CE; Gregory MC; Santi PA; Colvin R; Collins B; Nadol JB
Laryngoscope; 2004 Sep; 114(9):1609-18. PubMed ID: 15475791
[TBL] [Abstract][Full Text] [Related]
35. Mammalian auditory hair cell regeneration/repair and protection: a review and future directions.
Feghali JG; Lefebvre PP; Staecker H; Kopke R; Frenz DA; Malgrange B; Liu W; Moonen G; Ruben RJ; Van de Water TR
Ear Nose Throat J; 1998 Apr; 77(4):276, 280, 282-5. PubMed ID: 9581394
[TBL] [Abstract][Full Text] [Related]
36. Pathomorphological peculiarities of damage to hair cells of the organ of corti in experimental sensorineural hearing loss.
Zhuravskii SG; Borodulin VG; Tomson VV; Lopotko AI
Bull Exp Biol Med; 2006 Mar; 141(3):378-82. PubMed ID: 17073165
[TBL] [Abstract][Full Text] [Related]
37. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice.
Guo Y; Zhang C; Du X; Nair U; Yoo TJ
Hear Res; 2005 Oct; 208(1-2):54-67. PubMed ID: 16051453
[TBL] [Abstract][Full Text] [Related]
38. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
39. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
40. Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear implant electrode array.
Dinh C; Hoang K; Haake S; Chen S; Angeli S; Nong E; Eshraghi AA; Balkany TJ; Van De Water TR
Otol Neurotol; 2008 Oct; 29(7):1012-9. PubMed ID: 18818545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
